CD4+ cells from patients with Common Variable Immunodeficiency have a reduced ability of CD40 ligand membrane expression after in vitro stimulation

Pediatr Allergy Immunol. 1996 Nov;7(4):176-9. doi: 10.1111/j.1399-3038.1996.tb00129.x.

Abstract

Background: Common Variable Immunodeficiency (CVID) is characterized by defective antibody production. This has been variably attributed to intrinsic B-cell defects or to T-cell disfunctions. Recently, it has been reported that the expression of the CD40 Ligand (CD40L), a T-cell surface molecule that plays a critical role in the cell-contact-mediated helper signals provided to B-cells, is defective in a subset of patients with CVID.

Methods: To demonstrate that the defective expression is due to intrinsic functional abnormalities of CD4+ lymphocytes, CD4+ cells were purified from eight patients with CVID and eight age-paired controls, stimulated with PMA+Ionomycin, and studied for CD40L expression by flow cytometry using specific monoclonal antibodies.

Results and conclusions: The percentage of CD4+ cells expressing CD40L after optimal stimulation was correlated with age both in patients with CVID (r: 0.74; p: 0.04) and in healthy controls (r: 0.73; p: 0.04). The percentage of CD40L+ cells was reduced in patients with CVID compared to that of controls (p: 0.02 when data are paired for age) with a reduced density of expression (p: < 0.01). The defect was variable in different patients and in some cases it was marginal.

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • CD4-Positive T-Lymphocytes / chemistry*
  • CD40 Ligand
  • Child
  • Common Variable Immunodeficiency / immunology*
  • Female
  • Humans
  • Lymphocyte Activation*
  • Male
  • Membrane Glycoproteins / analysis*

Substances

  • Membrane Glycoproteins
  • CD40 Ligand